Enhanced deliverability** with advanced stent design

 

Improved flexibility10

The curved connectors combined with the Quadrature Link™ design give the Juno™ stent platform improved flexibility, while preserving stent security and vessel scaffolding.

 

Improved Trackability10

Less force needed with the BioMatrix Flex™ stent to navigate through tortuous vessels for improved deliverability**.

 

Larger Side Branch Access10

Improved initial cell opening to facilitate the side branch access.

Exceptional performance... Premium deliverability

BioMatrix Flex Delivery system


11184-000-EN - Rev.03 + 10801-000-EN - Rev.05 + 11881-000-EN - Rev. 04
BioMatrix NeoFlex™
Movie - How does it work?
Watch the working principle of our BioMatrix NeoFlex™ stent
BioMatrix NeoFlex™
Main brochure

BioMatrix NeoFlex™
Ordering information

** Deliverability defined as a combination of flexibility, trackability and pushability.
10. Compared to the BioMatrix™ stent platform – Internal bench testing – Flexibility and trackability: n=15 in each group, 3.0x28 mm stents – Side branch access: n=2 in each group, 3.0x28mm/3.0x18 mm stents – Bench test results may not necessarily be indicative of clinical outcomes.
BIOMATRIX™ FAMILY CLINICAL PROGRAM

CAUTION: Please note that the following pages are exclusively reserved for Health Care Professionals in countries with applicable health authority product registrations. To the extent this site contains information intended for use by licensed medical professionals, such materials are not intended to offer professional medical advice. Prior to use, please consult device labeling for prescriptive information and operating instructions. Please contact your Biosensors International representative for availability or the products and registration status.

The law restricts these devices to sale by or on the order of a physician. Prior to use, it is important to read the "Instructions for Use" supplied with these devices for indications, contraindications, suggested procedures, warnings, and precautions.

Biosensors’ interventional cardiology products, including BioMatrix NeoFlex™, BioMatrix™ Alpha, BioFreedom™, BioFreedom™ Ultra, Chroma™, BioStream™, BMX-J®, BioPath™, Powerline™, RISE™ NC, are not available for sale in the United States and certain other countries. ALLEGRA™ is a product of NVT AG. Blue Sail Medical Co., Ltd is the parent company of NVT AG and Biosensors International Group, Ltd. and its affliates are collaborating for the commercialization of the ALLEGRA™ device.

BioMatrix NeoFlex, BioMatrix Alpha, BioFreedom, BioFreedom Ultra, Chroma, BioStream, BMX-J, BioPath, Juno, S-Stent, Powerline, Rise NC and Quadrature Link are trademarks or registered trademarks of Biosensors International Group, Ltd. ALLEGRA is a trademark or registered trademark of NVT AG. ALLEGRA™ is CE Mark approved (CE 0124). All other cited trademarks are the property of their respective owners.